United States Pharmaceuticals Market ANÁLISE DE TAMANHO E PARTICIPAÇÃO - TENDÊNCIAS DE CRESCIMENTO E PREVISÕES (2023 - 2030)

United States Pharmaceuticals Market is Segmented By Product Type (Prescription Drugs, Generic Drugs, OTC Drugs, Biologics, Biosimilars), By Therapy Area (Oncology, Diabetes, Autoimmune Diseases, Neurological Disorders, Cardiovascular, Infectious Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Oral, Parenteral, Topical), By End User (Hospitals, Clinics, Homecare Settings). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of United States Pharmaceuticals Market

Os principais jogadores que operam no mercado farmacêutico dos Estados Unidos incluem Johnson e Johnson Inc., Pfizer Inc., AbbVie Inc., Merck KGaA, Bristol-Myers Squibb Company, Amgen Inc., Eli Lilly e Company, Novartis AG, Gilead Sciences, Inc. , F. Hoffmann-La Roche Ltd, Sanofi, AstraZeneca, GSKer plc.

United States Pharmaceuticals Market Leaders

  • Johnson e Johnson Inc.
  • Pfizer Inc.
  • AbbVie Inc.
  • Merck KGaA
  • Bristol-Myers Squibb Company
*Disclaimer: Major players are listed in no particular order.

United States Pharmaceuticals Market - Competitive Rivalry, 2023

Market Concentration Graph

United States Pharmaceuticals Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights